As gastric cancer is one of the leading causes of cancer-related death worldwide, it is urgent to discover new agent for gastric cancer treatment, and HDAC6 is the target we chose for the application of drug repurposing strategy in this study due to the significant role of HDAC6 in the progression of gastric cancer. Here, HDAC6 is linked to cancer.